D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Visa
V
|
+$319M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$288M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$226M |
| 4 |
American Express
AXP
|
+$206M |
| 5 |
Salesforce
CRM
|
+$204M |
Top Sells
| 1 |
PayPal
PYPL
|
+$504M |
| 2 |
Exxon Mobil
XOM
|
+$356M |
| 3 |
Bank of America
BAC
|
+$244M |
| 4 |
Netflix
NFLX
|
+$182M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| 1 | Technology | 19.32% |
| 2 | Financials | 13.76% |
| 3 | Healthcare | 11% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
601
DELISTED
Amedisys
AMED
| $14.8M | 0.02% |
152,777
-45,624
| -23% | -$4.42M |
|
602
Xenon Pharmaceuticals
XENE
$2.94B
| $14.8M | 0.02% |
409,563
+83,021
| +25% | +$3M |
|
|
SAMA
603
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
| $14.8M | 0.02% |
1,485,000
| – | – |
|
|
KRNL
604
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $14.8M | 0.02% |
1,487,583
+931,988
| +168% | +$9.25M |
|
|
HTPA
605
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $14.7M | 0.02% |
1,479,227
+852,635
| +136% | +$8.49M |
|
|
TCOA
606
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $14.7M | 0.02% |
1,485,000
| – | – |
|
|
AUY
607
DELISTED
Yamana Gold, Inc.
AUY
| $14.7M | 0.02% |
3,248,025
+3,180,261
| +4,693% | +$14.4M |
|
608
Manulife Financial
MFC
$52.2B
| $14.7M | 0.02% |
935,240
+396,300
| +74% | +$6.21M |
|
|
WRK
609
DELISTED
WestRock Company
WRK
| $14.6M | 0.02% |
473,707
+209,852
| +80% | +$6.48M |
|
|
PEGR
610
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $14.6M | 0.02% |
1,485,000
| – | – |
|
|
DCPH
611
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.6M | 0.02% |
790,411
+623,526
| +374% | +$11.5M |
|
612
Evolent Health
EVH
$1.11B
| $14.6M | 0.02% |
406,944
-105,210
| -21% | -$3.78M |
|
613
NETSCOUT
NTCT
$1.79B
| $14.6M | 0.02% |
464,887
+26,683
| +6% | +$836K |
|
614
Manhattan Associates
MANH
$13.3B
| $14.5M | 0.02% |
109,007
-31,821
| -23% | -$4.23M |
|
|
ROSE
615
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
| $14.5M | 0.02% |
1,422,727
| – | – |
|
616
Estee Lauder
EL
$32B
| $14.4M | 0.02% |
66,872
+10,065
| +18% | +$2.17M |
|
617
Cameco
CCJ
$33.6B
| $14.4M | 0.02% |
542,364
+107,739
| +25% | +$2.86M |
|
618
iHeartMedia
IHRT
$338M
| $14.4M | 0.02% |
1,961,199
| – | – |
|
619
Constellium
CSTM
$2B
| $14.4M | 0.02% |
1,415,549
+119,867
| +9% | +$1.22M |
|
|
GWII
620
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
| $14.3M | 0.02% |
1,429,271
+1,018
| +0.1% | +$10.2K |
|
621
Conagra Brands
CAG
$9.32B
| $14.3M | 0.02% |
437,987
-47,507
| -10% | -$1.55M |
|
622
Sensata Technologies
ST
$4.66B
| $14.3M | 0.02% |
382,810
+316,193
| +475% | +$11.8M |
|
623
Box
BOX
$4.8B
| $14.2M | 0.02% |
582,709
+150,191
| +35% | +$3.66M |
|
624
ADMA Biologics
ADMA
$3.92B
| $14.2M | 0.02% |
5,843,796
+1,011,404
| +21% | +$2.46M |
|
|
EQC
625
DELISTED
Equity Commonwealth
EQC
| $14.2M | 0.02% |
581,521
-124,996
| -18% | -$3.04M |
|